Categories for... News

News

Sygnature appoints Dr David Lustig to spearhead US expansion

READ ARTICLE

Drug Discovery News

Sygnature Discovery expands US presence with Bay Area office

READ ARTICLE

News

Legendary Werewolf: A Freak Chemistry Accident at Sygnature!

READ ARTICLE

DMPK in vivo pharmacology News

Leading UK Drug Discovery CROs Unite as Sygnature Discovery

READ ARTICLE

Drug Discovery News

Sygnature Discovery Opens Second Drug Discovery Site at Alderley Park

READ ARTICLE

Blog Events News

Powerful Webinar Series Unites Sygnature and Altasciences

READ ARTICLE

Awards News

Sygnature Discovery named Company of the Year at Bionow Annual Awards

READ ARTICLE

Computational Sciences and Informatics Drug Discovery News

Enhancing Molecular Design Services: Sygnature Discovery Adopts OpenEye’s Orion™ Platform

READ ARTICLE

Awards News

Sygnature Discovery shortlisted for BioNow Company of the Year Award

READ ARTICLE

Bioscience News

Sygnature upgrades western blotting capability with Jess instrument from Protein Simple

READ ARTICLE

News

Dr Paul Overton becomes Chief Commercial Officer (CCO) at Sygnature Discovery

READ ARTICLE

News

What happened? A 2020 Recap!

READ ARTICLE